Media

IPN Opinion article

May 10, 2005
Alec van Gelder writes in the Wall Street Journal Europe that the proposals to circumvent property rights made by the self-styled "friends of development", a group of NGOs and Governments from poorer countries, are misguided in their attempts to improve access to medicines, among other things.

IPN Opinion article

May 7, 2005
Discusses Looking Back to Look Beyond, a new book by Bibek Debroy and Mohammed Saqib: "Julian Morris raises the subject of environmental protection, including the rather dubious conceptualisation of the trade-environment nexus by certain environment groups, as well as the desire of certain eco-extremist organisations to push an anti-trade agenda. "

IPN Opinion article

April 25, 2005
Despite the WHO's pledge to halve the number of malaria cases by 2010, the disease seems to be on the increase. IPN's Philip Stevens examines what is going wrong for the WHO, and suggests that a winning strategy must involve DDT spraying in dwellings.

IPN Opinion article

February 22, 2005

IPN Opinion article

January 31, 2005
NO ONE can accuse the World Health Organisation (WHO) of lacking ambition in its attempts to get to grips with the AIDS crisis sweeping much of sub-Saharan Africa. Its "three by five" initiative - a plan to put 3-million people on lifeextending antiretroviral treatment by the end of this year - is arguably the single biggest push that any multilateral body has yet undertaken to try to tackle the disease. Unfortunately, according to figures released last week by the WHO, the project looks like its going to miss its target spectacularly.

IPN Opinion article

January 26, 2005

IPN Opinion article

January 12, 2005
The strategic documents coming out of the WHO lay bare the power the big NGOs now have in shaping its agenda - and it is an agenda that promotes the failed redistributory economics of the past.

IPN Opinion article

November 29, 2004
Activists' claims that too many resources are being devoted to finding cures for the diseases of the rich at the expense of the poor are both wrong and dangerous. By using this as a spurious justicification to reform the way in which R&D is conducted will have the unintended consequence of stifling the innovation that will provide us with drugs to combat the diseases of the future.

IPN Opinion article

September 10, 2004